Roflumilast Tablets, For Oral Use

Roflumilast Tablets, For Oral Use
SPL v4
SPL
SPL Set ID e87287bd-eae3-46c3-9072-04800aeabf40
Route
ORAL
Published
Effective Date 2024-08-12
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Roflumilast (500 ug)
Inactive Ingredients
Cellulose, Microcrystalline Hydroxypropyl Cellulose, Low Substituted Lactose Monohydrate Magnesium Stearate Poloxamer 407 Silicon Dioxide Starch, Corn

Identifiers & Packaging

Pill Appearance
Imprint: T6 Shape: round Color: white Size: 6 mm Score: 1
Marketing Status
ANDA Active Since 2023-05-18

Description

NDC 70771-1674-3 Roflumilast Tablets, 500 mcg 30 tablets Rx only NDC 70771-1673-8 Roflumilast Tablets, 250 mcg Blister pack of 28 tablets Rx only


Medication Information

Description

NDC 70771-1674-3 Roflumilast Tablets, 500 mcg 30 tablets Rx only NDC 70771-1673-8 Roflumilast Tablets, 250 mcg Blister pack of 28 tablets Rx only

Package Label.principal Display Panel

NDC 70771-1674-3

Roflumilast Tablets, 500 mcg

30 tablets

Rx only

NDC 70771-1673-8

Roflumilast Tablets, 250 mcg

Blister pack of 28 tablets

Rx only


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

NDC 70771-1674-3

Roflumilast Tablets, 500 mcg

30 tablets

Rx only

NDC 70771-1673-8

Roflumilast Tablets, 250 mcg

Blister pack of 28 tablets

Rx only


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)